« Previous AbstractLong-term antibody production after lung immunization and challenge: role of lung and lymphoid tissues    Next AbstractAcetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs »

Anaesthesia

Title:		Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve')
Author(s):		Tehan, B. Hardern, R. Bodenham, A.
Address:		Leeds General Infirmary.
Year:		1993 Jun
Journal Title:		Anaesthesia
Page Number:		507-10
Language:		eng
Volume:		48
Issue:		6
ISSN/ISBN:		0003-2409 (Print)
Abstract:		A patient was admitted with hyperthermia, muscle rigidity, rhabdomyolysis and disseminated intravascular coagulation. He was initially thought to have taken 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), but subsequent toxicology revealed the presence of 3,4-methylenedioxyethamphetamine (MDEA, 'Eve'), its sister drug, in his blood. Subsequent in vitro testing for malignant hyperthermia proved to be negative.